3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell, Peripheral
5
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, T-Cell
3
Lymphoma
2
Immunoblastic Lymphadenopathy
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Mycosis Fungoides
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Prolymphocytic, T-Cell
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Temozolomide
8
Radiotherapy
7
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Vincristine
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Procarbazine
2
Lomustine
2
vorasidenib
1
vocimagene amiretrorepvec
1
trametinib
1
pemigatinib
1
pembrolizumab
1
mirdametinib
1
fluorodopa F 18
1
dabrafenib
1
abexinostat
1
abemaciclib
1
Vorinostat
1
Tretinoin
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Conformal
1
Protons
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
romidepsin
×
1 year
×
Clear all
No trials found.